Fierce Pharma

JUNE 6, 2024

Amid a nuclear medicine boom, France’s Orano Med has chosen the U.S. The site marks the world’s first industrial-scale facility dedicated to production of lead-212-based radioligand therapies, the company said. to establish a manufacturing plant as it progresses on its radiopharma journey.

Manufacturing 246

Manufacturing Medicine Leads 246

World of DTC Marketing

JUNE 5, 2021

There is disagreement whether obesity is really considered a disease or a behavioral risk factor, similar to smoking, alcohol, and substance abuse that may lead to disease. Some of the environmental conditions that lead to obesity are physical activity, alcohol consumption, socioeconomic status, parent feeding behavior, and diet.

Government 193

Government Medicine Food Management 193

pharmaphorum

APRIL 29, 2024

George Medicines has appointed former Ironwood CEO Mark Mallon to lead the company as it tries to get its triple therapy for hypertension over the finish line.

Medicine 105

Medicine Leads 105

pharmaphorum

OCTOBER 28, 2022

In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Angela McFarlane ?,

Medicine 122

Medicine Management Marketing Leads 122

European Pharmaceutical Review

FEBRUARY 21, 2023

The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. In this Q&A, EPR caught up with CEO James Short and Managing Director Arthur Wakeley from Celadon, to learn more about the company’s experience moving through, and progressing, the strict regulatory process for medicinal cannabis.

Medicine 132

Medicine Manufacturing Specialization Pharmaceutical 132

MedCity News

JULY 7, 2023

This includes mental health, physical medicine and rehabilitation and pain medicine, which all had a more than 20% higher follow-up rate after an in-person office appointment than a telehealth appointment.

Leads 135

Leads Medicine 135

Pharmaceutical Technology

JANUARY 16, 2023

CARsgen Therapeutics has announced a col labor ation with Huadong Medicine to commercialise zevorcabtagene autoleucel (zevor-cel), CT053, in mainland China. Under the collaboration, Huadong Medicine will have the exclusive right to commercialise CARsgen’s CT053 in mainland China.

Medicine 119

Medicine Food and Drug Administration Food Medical 119

European Pharmaceutical Review

FEBRUARY 22, 2024

This is “an important milestone” according to Lynn Clay, Specialty Care Lead at Pfizer UK. However, on 31 October 2023, a marketing authorisation in Great Britain was granted for the medicine ritlecitinib. “It The post NICE recommends first medicine for severe alopecia areata appeared first on European Pharmaceutical Review.

Medicine 98

Medicine Healthcare Healthcare Leads 98

European Pharmaceutical Review

MAY 2, 2024

Two trends that I expect to continue in the foreseeable future are the move towards precision medicine and the diversification of the biologics chemical structures. There have been upward of 1,900 precision medicine clinical trials conducted to date. Available from: [link] The post What is the future of biologic medicines?

Medicine 105

Medicine Manufacturing Biopharma Engineering 105

European Pharmaceutical Review

FEBRUARY 2, 2023

While maintaining a healthy manufacturing industry for production of ‘high tech’ pharmaceuticals, Europe has stepped away from manufacturing essential medicines and active pharmaceutical ingredients (APIs) due to unrelenting price pressures and is now heavily reliant on the import of these critical ingredients.

Medicine 111

Medicine Manufacturing Pharmaceutical Specialization 111

Pharmaceutical Technology

DECEMBER 23, 2022

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology. Optimise your cell therapy process: a guide to cell thawing.

Medicine 131

Medicine Pharmaceutical Marketing Sales 131

European Pharmaceutical Review

JANUARY 25, 2023

The European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for exagamglogene autotemcel (exa-cel), the first regulatory submission for a CRISPR-based medicine. Under an amended collaboration agreement, Vertex now leads global development, manufacturing and commercialisation of exa-cel.

Medicine 111

Medicine Food and Drug Administration FDA Pharmaceutical 111

pharmaphorum

JANUARY 24, 2023

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. Medicines and medical technology manufacturing delivered annual exports worth over £30 billion ($37 billion) for the UK in 2019, on top of making a £32.1 It’s not all bad news.

Manufacturing 111

Manufacturing Medicine Government Pharmaceutical manufacturing 111

MedCity News

SEPTEMBER 20, 2023

This accelerates lead identification and optimization, offering researchers a broader pool of candidates to choose from. From revolutionizing drug discovery and design to enabling personalized medicine and accelerating research, the benefits are vast and diverse.

Ethics 119

Ethics Medicine Pharmaceutical Pharmaceutical research 119

European Pharmaceutical Review

OCTOBER 22, 2024

The UK is set to be the first country to introduce a new regulatory framework for innovative products manufactured at or close to the point of patient care, says the Medicines and Healthcare products Regulatory Agency (MHRA). Introduction of this framework was originally announced by the MHRA in January 2023.

Medicine 89

Medicine Manufacturing Safety Consulting 89

European Pharmaceutical Review

JANUARY 11, 2024

What are the key current challenges in the development of pain medicines? What is the present clinical landscape for pain management medicines, especially chronic pain? Pain management therapies: Pfizer’s migraine medicine recommended by NICE What are three current development trends for pain management treatments?

Medicine 102

Medicine Pharmacology Management Side effects 102

European Pharmaceutical Review

NOVEMBER 15, 2023

[Sandoz] has the only major remaining vertically-integrated production network for penicillins in Europe” Penicillins are the leading category of antibiotics worldwide, Sandoz highlighted. The post Sandoz mobilises critical medicine production in Europe appeared first on European Pharmaceutical Review.

Medicine 93

Medicine Manufacturing Networking Biopharma 93

MedCity News

APRIL 17, 2023

Merck is acquiring Prometheus Biosciences and a lead drug candidate in development for inflammatory bowel disorders. The deal comes as Merck looks for drug prospects that could make up for revenue declines facing blockbuster seller Keytruda, which faces patent expirations in coming years.

Medicine 117

Medicine Prospecting Leads Biopharma 117

World of DTC Marketing

FEBRUARY 17, 2022

But it’s still the leading cause of cancer deaths. Although lung cancer’s mortality rate has fallen, the disease is still the leading cause of cancer deaths. According to a team of Penn State College of Medicine researchers, care for the 15 most prevalent types of cancer in the U.S. American Cancer Society’s ACS ).

Medicine 271

Medicine Insurance Leads Medical 271

PharmaVoice

DECEMBER 2, 2024

Intrinsic Medicines is entering phase 2 trials in Parkinson’s disease and IBS for its human milk oligosaccharide drug candidates next year.

Leads 98

Leads Medicine 98

European Pharmaceutical Review

DECEMBER 22, 2022

Advances in mRNA technologies and cellular delivery systems coupled with their cost effectiveness, manufacturing simplicity and ability to target previously-undruggable pathways has limitless potential that could revolutionise medicine. 2022) The Progress and Promise of RNA Medicine – An Arsenal of Targeted Treatments. References.

Medicine 116

Medicine Food and Drug Administration Transportation Distribution 116

World of DTC Marketing

OCTOBER 21, 2021

SUMMARY: Medicare spent nearly $600 million over a three-year period to pay for four cancer drugs with no clinical benefit an analysis published Monday by JAMA Internal Medicine found. Between 2011 and 2018, cumulative spending on 44 FDA-approved oral targeted therapy drugs was $3.5

FDA 234

FDA Insurance Prescription Medicine 234

World of DTC Marketing

JULY 31, 2021

Whenever possible, I have tried to share information from leading physicians to help others understand exactly what’s going on. He is Chair of UCSF Department of Medicine and has been actively sharing his thoughts on the latest COVID information. Take, for example, Dr. Bob Wachter.

Media 253

Media Doctors Physicians Medicine 253

pharmaphorum

FEBRUARY 23, 2024

Bavarian Nordic will get an accelerated review of its chikungunya vaccine CHIKV VLP at the EMA, as it tries to chase down a lead held by rival Valneva.

Medicine 124

Medicine Pharma Leads 124

Pharma Marketing Network

DECEMBER 19, 2024

For marketing executives, understanding the significance of leading pharma brands is essential. Companies like Pfizer, Roche, and Johnson & Johnson not only lead in sales but also innovate in marketing strategies that connect with both healthcare professionals and consumers. How do personalized medicines impact pharma marketing?

Leads 52

Leads Pharma Education Marketing 52

World of DTC Marketing

NOVEMBER 18, 2021

group that reviews the value of medicines said on Tuesday. leading to an almost $1.4 According to Fierce Pharma “AbbVie has filed for 165 patents on Imbruvica, and officials have granted 88 of them, the Initiative for Medicines, Access & Knowledge reports. According to Reuters “drugmakers hiked U.S.

Pharma 202

Pharma Medicine Prescription Manufacturing 202

World of DTC Marketing

DECEMBER 1, 2021

OPENING: TV is great at creating awareness, but it can also scare patients away if one of your side effects is “may lead to death.” The side effects: Bleeding problems (hemorrhage) are common during treatment with IMBRUVICA® and can be severe and lead to death. Heart problems.

Side effects 210

Side effects Doctors Physicians Leads 210

MedCity News

FEBRUARY 3, 2023

Much of the new cash will support its lead program, an oral small molecule that could weigh in on the diabetes and obesity indications currently dominated by blockbuster injectable medicines. Despite challenging financial market conditions, clinical-stage Structure Therapeutics was able to upsize its IPO.

Medicine 119

Medicine Leads Marketing Biopharma 119

MedCity News

AUGUST 1, 2024

Otsuka Pharmaceutical is acquiring Jnana Therapeutics, whose lead drug is a potential treatment for the rare metabolic disorder phenylketonuria (PKU). Jnana’s drug could provide an alternative to two FDA-approved PKU medicines from BioMarin Pharmaceutical.

Pharmaceutical 109

Pharmaceutical Medicine FDA Leads 109

Pharmaceutical Technology

OCTOBER 9, 2024

City Therapeutics has announced its launch accompanied by a $135m Series A financing to lead advancements in RNAi-based medicine.

Medicine 98

Medicine Leads 98

MedCity News

JANUARY 21, 2024

The FDA said Amgen’s Prolia may lead to low levels of calcium, or hypocalcemia. The osteoporosis drug’s black box warning follows an FDA review of Centers for Medicare & Medicaid Services studies that found Prolia led to a significant increase in the risk of severe hypocalcemia compared to treatment with an older class of medicines.

FDA 105

FDA Medicine Leads Biopharma 105

PharmaTimes

MARCH 28, 2024

Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m

Leads 97

Leads Electronics Medicine 97

World of DTC Marketing

AUGUST 29, 2022

At a recent online seminar, a leading biotech company had over 200 oncologists discuss “helping patients understand their treatment.” Most physicians are trained in medicine and rely on their experiences to understand patients. HCPs want to understand their patients better as insurers require better patient outcomes.

Side effects 203

Side effects Physicians Insurance Marketing 203

World of DTC Marketing

JUNE 20, 2022

Some will lead to more online research, while others may not. Pharma DTC marketing is unique, and drug marketers need to think more about the journey from awareness to requesting an Rx. In addition, the patient journey is different for each product category and audience.

Pharma 210

Pharma Side effects Media Prescription 210

pharmaphorum

JULY 2, 2024

Apellis Pharma has said it will seek a re-evaluation of its marketing application for Syfovre for eye disease geographic atrophy (GA) after the EMA’s human medicines committee turned it down for a second time.The CHMP said at its late June meeting that it was issuing a negative opinion for Syfovre (pegcetacoplan) for the treatment of GA secondary to (..)

Medicine 105

Medicine Pharma Leads Marketing 105

World of DTC Marketing

FEBRUARY 1, 2022

According to STAT News “after a double-digit decline in 2021, the sector has fallen another 20% in the new year, erasing billions in value and leading even the most seasoned investors to question whether biotech has further to fall. Can small biotech companies survive? The post A perfect storm for biotech stocks.

Food and Drug Administration 234

Food and Drug Administration FDA Pharmaceutical Food 234

European Pharmaceutical Review

MAY 12, 2023

Innovative therapies for rare diseases The acquisition will help to drive the growth of CTI’s lead product, kinase inhibitor VONJO ® (pacritinib) “in treating myeloproliferative disease,” stated Dr Adam Craig, President, Chief Executive Officer and Interim Chief Medical Officer of CTI BioPharma.

Food and Drug Administration 105

Food and Drug Administration Biopharma Medicine Food 105